Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
7.70
0.12 (1.52%)
At close: Aug 15, 2025, 3:59 PM
7.70
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Aligos Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.17M | 3.27M | 3.94M | 6M | 7.97M | 13.79M | 15.53M | 16.39M | 17.25M | 14.06M | 13.91M | 10.74M | 8.17M | 6.02M | 4.36M | 3.99M | 4.48M | 2.94M |
Cost of Revenue | 259K | 610K | 1.28M | 2.06M | 2.74M | 2.9M | 3.07M | 3.19M | 3.42M | 3.54M | 3.67M | 31.38M | 58.6M | 82.27M | 104.15M | 103.64M | 92.84M | 85.46M |
Gross Profit | 2.24M | 1.99M | 1.99M | 3.94M | 5.23M | 10.89M | 12.46M | 13.19M | 13.84M | 10.52M | 10.23M | -20.64M | -50.43M | -76.25M | -99.79M | -99.64M | -88.36M | -82.52M |
Operating Income | -78.5M | -86.35M | -89.15M | -94.59M | -93.53M | -86.25M | -86.12M | -82.81M | -82.69M | -83.94M | -97.58M | -112.85M | -126.97M | -136.14M | -128.32M | -124.66M | -113.15M | -104.85M |
Interest Income | 2.01M | 1.93M | 1.67M | 2.94M | 3.49M | 4.13M | 4.3M | 3.55M | 3.01M | 2.27M | 1.61M | 940K | 494K | 354K | 373K | 197K | 411K | 713K |
Pretax Income | -73.84M | -52.91M | -130.88M | -76.68M | -75.52M | -98.81M | -86.88M | -80.8M | -81.45M | -83.29M | -95.94M | -111.88M | -126.21M | -136.12M | -128.19M | -124.62M | -124.92M | -115.98M |
Net Income | -74.18M | -53.26M | -131.21M | -76.95M | -75.73M | -99.59M | -87.68M | -81.67M | -82.25M | -83.39M | -96.05M | -111.87M | -126.38M | -136.27M | -128.33M | -125.04M | -125.21M | -116.19M |
Selling & General & Admin | 20.14M | 20.61M | 22.22M | 22.7M | 24.52M | 28M | 29.84M | 31.31M | 30.13M | 28.46M | 26.41M | 29.01M | 30.22M | 29.2M | 28.53M | 25.02M | 22.77M | 20.31M |
Research & Development | 61.28M | 68.41M | 70.27M | 76.5M | 75.59M | 71.27M | 73.04M | 69.88M | 71.81M | 71.54M | 85.08M | 94.58M | 104.92M | 112.96M | 104.15M | 103.64M | 92.84M | 85.46M |
Other Expenses | n/a | n/a | -13.37M | -13.37M | -13.32M | -13.17M | 460K | 460K | 224K | 376K | 31K | 31K | 263K | -339K | -242K | 828K | -11.2M | -10.86M |
Operating Expenses | 81.42M | 89.01M | 92.49M | 99.2M | 100.11M | 99.27M | 102.88M | 101.2M | 101.94M | 100M | 111.49M | 123.58M | 135.13M | 142.16M | 132.68M | 128.65M | 115.6M | 105.76M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 876K | 876K | 876K | 876K | 132K | 132K | 132K | 132K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -610K | -610K | -1.39M | -1.39M | -775K | -775K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 81.68M | 89.62M | 93.1M | 100.58M | 101.5M | 100.05M | 103.66M | 101.2M | 101.94M | 100M | 111.49M | 123.58M | 135.13M | 142.16M | 132.68M | 128.65M | 115.6M | 105.76M |
Income Tax Expense | 346K | 350K | 283K | 226K | 164K | 732K | 795K | 874K | 802K | 92K | 106K | -1K | 168K | 149K | 141K | 418K | 58K | -29K |
Shares Outstanding (Basic) | 10.35M | 8.41M | 6.28M | 6.27M | 6.26M | 156.15M | 24.87M | 43.5M | 43.22M | 42.91M | 42.84M | 42.76M | 42.67M | 42.51M | 42.34M | 42.4M | 37.62M | 37.43M |
Shares Outstanding (Diluted) | 10.35M | 8.71M | 6.28M | 6.27M | 6.27M | 156.15M | 24.87M | 43.5M | 43.22M | 42.91M | 42.84M | 42.76M | 42.67M | 42.51M | 42.34M | 42.4M | 37.62M | 37.43M |
EPS (Basic) | -12.56 | -10.22 | -20.92 | -8.96 | -6.3 | -7.54 | -2.49 | -1.88 | -1.91 | -1.95 | -2.26 | -2.64 | -2.98 | -3.3 | -3.2 | -3.4 | -3.52 | -3.68 |
EPS (Diluted) | -19.79 | -17.45 | -20.92 | -8.96 | -6.3 | -7.54 | -2.49 | -1.88 | -1.91 | -1.95 | -2.26 | -2.64 | -2.98 | -3.3 | -3.2 | -3.4 | -3.52 | -3.68 |
EBITDA | -73.51M | -84.5M | -87.14M | -94.4M | -93.32M | -85.28M | -86.98M | -82M | -81.36M | -82.5M | -94M | -109.79M | -124.06M | -133.42M | -125.6M | -120.97M | -109.78M | -101.23M |
EBIT | -75.61M | -86.35M | -89.15M | -94.59M | -93.53M | -86.25M | -88.13M | -84.81M | -84.69M | -85.94M | -97.58M | -112.85M | -126.97M | -136.14M | -128.32M | -124.66M | -113.15M | -104.85M |
Depreciation & Amortization | 2.11M | 2.46M | 2.62M | 2.73M | 2.74M | 2.9M | 3.07M | 3.19M | 3.42M | 3.54M | 3.67M | 3.79M | 3.85M | 3.89M | 3.78M | 3.65M | 3.57M | 3.74M |